Ovid Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Revenue	0.57	0.39	1.5	208.38	12.62	Upgrade
Revenue Growth (YoY)	44.39%	-73.91%	-99.28%	1551.57%	-	Upgrade
Gross Profit	0.57	0.39	1.5	208.38	12.62	Upgrade
Selling, General & Admin	23.88	29.59	32.43	37.23	30.63	Upgrade
Research & Development	35.07	28.39	24.62	46.94	63.42	Upgrade
Operating Expenses	58.95	57.97	57.05	84.17	94.05	Upgrade
Operating Income	-58.39	-57.58	-55.55	124.21	-81.43	Upgrade
Interest & Investment Income	-	-	-	-	0.4	Upgrade
Other Non Operating Income (Expenses)	32.1	4.94	1.83	-0.05	-	Upgrade
EBT Excluding Unusual Items	-26.28	-52.64	-53.71	124.16	-81.04	Upgrade
Merger & Restructuring Charges	-3.5	-1.7	-	-	-	Upgrade
Gain (Loss) on Sale of Investments	3.35	2	-0.45	-	-	Upgrade
Pretax Income	-26.43	-52.34	-54.17	124.16	-81.04	Upgrade
Income Tax Expense	-	-	-	1.33	-	Upgrade
Net Income	-26.43	-52.34	-54.17	122.83	-81.04	Upgrade
Preferred Dividends & Other Adjustments	-0.46	-0.91	-	3	-	Upgrade
Net Income to Common	-25.98	-51.43	-54.17	119.84	-81.04	Upgrade
Shares Outstanding (Basic)	71	71	70	67	58	Upgrade
Shares Outstanding (Diluted)	71	71	70	68	58	Upgrade
Shares Change (YoY)	0.46%	0.22%	3.46%	16.45%	49.05%	Upgrade
EPS (Basic)	-0.37	-0.73	-0.77	1.78	-1.39	Upgrade
EPS (Diluted)	-0.37	-0.73	-0.77	1.76	-1.39	Upgrade
Free Cash Flow	-56.03	-45.82	-56.45	118.43	-51.71	Upgrade
Free Cash Flow Per Share	-0.79	-0.65	-0.80	1.74	-0.89	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-10315.37%	-14689.03%	-3696.44%	59.61%	-645.40%	Upgrade
Profit Margin	-4589.22%	-13119.39%	-3604.66%	57.51%	-642.26%	Upgrade
Free Cash Flow Margin	-9898.76%	-11689.03%	-3756.55%	56.83%	-409.85%	Upgrade
EBITDA	-57.77	-57.01	-55.04	124.45	-81.12	Upgrade
EBITDA Margin	-	-	-	59.72%	-	Upgrade
D&A For EBITDA	0.61	0.57	0.51	0.24	0.31	Upgrade
EBIT	-58.39	-57.58	-55.55	124.21	-81.43	Upgrade
EBIT Margin	-	-	-	59.61%	-	Upgrade
Effective Tax Rate	-	-	-	1.07%	-	Upgrade
Revenue as Reported	0.57	0.39	1.5	208.38	12.62	Upgrade

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q